lysine has been researched along with bortezomib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
| Jaffrey, SR; Jiang, X; Xu, G | 1 |
| Fang, SU; Hsine, YH; Liang, YC; Liao, YJ; Lin, RJ; Lin, SY; Suk, FM | 1 |
| Kazmi, MA; Peeler, JC; Sakmar, TP; Schedin-Weiss, S; Soula, M | 1 |
1 review(s) available for lysine and bortezomib
| Article | Year |
|---|---|
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
4 other study(ies) available for lysine and bortezomib
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.
Topics: Adaptor Proteins, Signal Transducing; Boronic Acids; Bortezomib; Codon, Nonsense; HEK293 Cells; Humans; Immunoblotting; Intellectual Disability; Lysine; Microscopy, Fluorescence; Mutant Proteins; Nuclear Proteins; Peptide Hydrolases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Pyrazines; Ubiquitin-Protein Ligases; Ubiquitination | 2013 |
Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Topics: Antineoplastic Agents; Bortezomib; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Electrophoresis, Gel, Two-Dimensional; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Immunoblotting; Lysine; Mutation; Proteomics; Proto-Oncogene Proteins c-myc; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sumoylation | 2015 |
Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4.
Topics: Amino Acid Sequence; Arginine; Bortezomib; HEK293 Cells; Humans; Lysine; Neurons; Proteasome Endopeptidase Complex; Protein Binding; Receptors, Dopamine; Receptors, Dopamine D4; Ubiquitin; Ubiquitination | 2017 |